Ads
related to: pfizer
Search results
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 3 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in...
Morningstar· 3 days agoTherapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, ...
Department of Health - Abu Dhabi Partners with Pfizer to Advance Research in Sickle Cell Disease and...
The Pilot News· 5 days agoThe Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate,...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 1 day agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...
Chiefs TE Travis Kelce, Social Media Sensation Livvy Dunne Star in New Commercial: ‘Making...
MSN News· 1 day agoKansas City Chiefs All-Pro tight end Travis Kelce has been in the news for off-field reasons plenty...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 1 hour agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 3 days agoImage source: Getty Images. Which high-yielders stand out as attractive buys heading into this event? Healthcare titans AbbVie (NYSE: ABBV) and Pfizer...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
